Brave Asset Management Inc Sarepta Therapeutics, Inc. Transaction History

Brave Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	SELL	$117.53 - $155.99 $114,826 - $152,402	-977 Reduced 39.08%	1,523 $209,000
Q3 2022 Oct 13, 2022	SELL	$75.71 - $119.24 $88,959 - $140,107	-1,175 Reduced 31.97%	2,500 $276,000
Q2 2022 Jul 15, 2022	SELL	$62.69 - $88.44 $29,777 - $42,009	-475 Reduced 11.45%	3,675 $275,000
Q3 2021 Nov 02, 2021	BUY	$65.97 - $92.48 $273,775 - $383,792	4,150 New	4,150 $384,000
Q2 2021 Jul 27, 2021	SELL	$69.38 - $86.75 $216,812 - $271,093	-3,125 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$72.25 - $168.95 $225,781 - $527,968	3,125 New	3,125 $233,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Brave Asset Management Inc with notifications on news.